TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biopharmacon, AB
Closing information (x1000 DKK)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
169
|
302 | |
| Financial expenses |
42
|
22 | |
| Earnings before taxes |
1,430
|
79 | |
| EBITDA |
11
|
73 | |
| Total assets |
4,730
|
3,550 | |
| Current assets |
4,436
|
3,196 | |
| Current liabilities |
47
|
79 | |
| Equity capital |
4,623
|
3,373 | |
| - share capital |
70
|
73 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
97.7%
|
95.0% | |
| Turnover per employee |
169
|
302 | |
| Profit as a percentage of turnover |
846.2%
|
26.2% | |
| Return on assets (ROA) |
31.1%
|
2.8% | |
| Current ratio |
9438.3%
|
4045.6% | |
| Return on equity (ROE) |
30.9%
|
2.3% | |
| Change turnover |
-117
|
-232 | |
| Change turnover % |
57%
|
-41%
|
-43% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.